ESR1 and triple-negative breast carcinoma: TP53 and NF1 mutations were more frequently identified in triple negative breast cancers whereas CCND1, FGF3, FGF19, ESR1, and FGFR1 copy number gains were recurrent in tumors of luminal subtype.